Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
1998 Apr 28;959:4941-6. doi: 10.1073/pnas.95.9.4941.
Show Gene links
Show Anatomy links
Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1: implications for the ligand-binding site.
Dautzenberg FM
,
Wille S
,
Lohmann R
,
Spiess J
.
???displayArticle.abstract???
The nonselective human corticotropin-releasing factor receptor 1 (hCRF-R1) and the ligand-selective Xenopus CRF-R1 (xCRF-R1) were compared. To understand the interactions of sauvagine and ovine CRF, both high-affinity ligands for hCRF-R1 but surprisingly weak ligands for xCRF-R1, chimeric receptors of hCRF-R1 and xCRF-R1 followed by double or multiple point mutations were constructed. Binding studies and cAMP assays demonstrated that the N-terminal domain exhibited the complete ligand selectivity of xCRF-R1. The important region was mapped between amino acids 70 and 89; replacement of amino acids Arg76, Asn81, Gly83, Leu88, and Ala89 in hCRF-R1 with the corresponding amino acids of xCRF-R1 (Gln76, Gly81, Val83, His88, and Leu89) resulted in a receptor that had approximately 30-fold higher affinity for human/rat CRF than for sauvagine. Mutagenesis of these amino acids in xCRF-R1 to the human sequence completely abolished the ligand selectivity of xCRF-R1. Mutagenesis of amino acids 88 and 89 in hCRF-R1 or xCRF-R1 had only a minor (approximately 2.5-fold) effect on the ligand selectivity of the mutant receptor. Substitution of Arg76, Asn81, and Gly83 in hCRF-R1 with the corresponding sequence of xCRF-R1 (Gln76, Gly81, and Val83) resulted in a receptor with approximately 11-fold higher affinity for human/rat CRF compared with ovine CRF or sauvagine. When only two of these three amino acids were mutated, no effect on the ligand selectivity was observed. On the basis of these data, it is suggested that amino acids 70-89 of CRF-R1 are important for the ligand binding site.
Chang,
Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain.
1993, Pubmed
Chang,
Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain.
1993,
Pubmed
Chen,
Expression cloning of a human corticotropin-releasing-factor receptor.
1993,
Pubmed
Dautzenberg,
Identification of two corticotropin-releasing factor receptors from Xenopus laevis with high ligand selectivity: unusual pharmacology of the type 1 receptor.
1997,
Pubmed
,
Xenbase
Dixon,
Ligand binding to the beta-adrenergic receptor involves its rhodopsin-like core.
,
Pubmed
Donaldson,
Cloning and characterization of human urocortin.
1996,
Pubmed
Dunn,
Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?
1990,
Pubmed
Fong,
Localization of agonist and antagonist binding domains of the human neurokinin-1 receptor.
1992,
Pubmed
,
Xenbase
Gourlet,
The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptors.
1996,
Pubmed
Hashimoto,
Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide receptor chimeras reveal domains that determine specificity of vasoactive intestinal polypeptide binding and activation.
1997,
Pubmed
Hausmann,
Mutational analysis and molecular modeling of the nonapeptide hormone binding domains of the [Arg8]vasotocin receptor.
1996,
Pubmed
,
Xenbase
Huang,
Interaction of substance P with the second and seventh transmembrane domains of the neurokinin-1 receptor.
1994,
Pubmed
Huang,
Localization of the ligand binding site of the neurokinin-1 receptor: interpretation of chimeric mutations and single-residue substitutions.
1994,
Pubmed
Ishihara,
Molecular cloning and expression of a cDNA encoding the secretin receptor.
1991,
Pubmed
Ishihara,
Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide.
1992,
Pubmed
Kishimoto,
A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle.
1995,
Pubmed
Lederis,
Complete amino acid sequence of urotensin I, a hypotensive and corticotropin-releasing neuropeptide from Catostomus.
1982,
Pubmed
Liaw,
Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid.
1996,
Pubmed
Liaw,
Localization of ligand-binding domains of human corticotropin-releasing factor receptor: a chimeric receptor approach.
1997,
Pubmed
Lovenberg,
Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain.
1995,
Pubmed
Mayo,
Molecular cloning and expression of a pituitary-specific receptor for growth hormone-releasing hormone.
1992,
Pubmed
Montecucchi,
Amino acid composition and sequence analysis of sauvagine, a new active peptide from the skin of Phyllomedusa sauvagei.
1981,
Pubmed
Nehring,
Aspartic acid residue 124 in the third transmembrane domain of the somatostatin receptor subtype 3 is essential for somatostatin-14 binding.
1995,
Pubmed
Orth,
Clinical studies with synthetic ovine corticotropin-releasing factor.
1985,
Pubmed
Owens,
Physiology and pharmacology of corticotropin-releasing factor.
1991,
Pubmed
Perrin,
The first extracellular domain of corticotropin releasing factor-R1 contains major binding determinants for urocortin and astressin.
1998,
Pubmed
Perrin,
Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor.
1993,
Pubmed
Perrin,
Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart.
1995,
Pubmed
Rühmann,
Synthesis and characterization of a photoactivatable analog of corticotropin-releasing factor for specific receptor labeling.
1996,
Pubmed
Spiess,
Primary structure of corticotropin-releasing factor from ovine hypothalamus.
1981,
Pubmed
Stenzel,
Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart.
1995,
Pubmed
Stenzel-Poore,
Characterization of the genomic corticotropin-releasing factor (CRF) gene from Xenopus laevis: two members of the CRF family exist in amphibians.
1992,
Pubmed
,
Xenbase
Strader,
Structural basis of beta-adrenergic receptor function.
1989,
Pubmed
Svoboda,
Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts.
1994,
Pubmed
Vale,
Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin.
1981,
Pubmed
Vaughan,
Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor.
1995,
Pubmed
Vita,
Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors.
1993,
Pubmed
Wheatley,
Peptide mapping studies on muscarinic receptors: receptor structure and location of the ligand binding site.
1988,
Pubmed
Yu,
Molecular cloning of a type A chicken corticotropin-releasing factor receptor with high affinity for urotensin I.
1996,
Pubmed